Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Disease-Free Survival"" wg kryterium: Temat


Tytuł :
No sex-related difference in achievement of treatment-free remission following treatment with tyrosine kinase inhibitors in chronic myeloid leukemia.
Autorzy :
Yamaguchi H; Department of Hematology, Nippon Medical School, 1-1-5 Sendagi, Bunkyo-Ku, Tokyo, 113-8603, Japan. .
Inokuchi K; Department of Hematology, Nippon Medical School, 1-1-5 Sendagi, Bunkyo-Ku, Tokyo, 113-8603, Japan.
Pokaż więcej
Corporate Authors :
of the Kanto CML Study Group
Źródło :
International journal of hematology [Int J Hematol] 2020 Jun; Vol. 111 (6), pp. 904. Date of Electronic Publication: 2020 Mar 31.
Typ publikacji :
Letter
Journal Info :
Publisher: Springer Japan Country of Publication: Japan NLM ID: 9111627 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1865-3774 (Electronic) Linking ISSN: 09255710 NLM ISO Abbreviation: Int. J. Hematol. Subsets: MEDLINE
MeSH Terms :
Disease-Free Survival*
Remission Induction*
Sex Characteristics*
Leukemia, Myelogenous, Chronic, BCR-ABL Positive/*drug therapy
Protein-Tyrosine Kinases/*antagonists & inhibitors
Female ; Follow-Up Studies ; Humans ; Male
Opinia redakcyjna
Tytuł :
Does patient sex play a role in treatment-free remission in chronic myeloid leukemia?
Autorzy :
Ureshino H; Division of Hematology, Respiratory Medicine and Oncology, Department of Internal Medicine, Saga University, 5-1-1 Nabeshima, Saga, 849-8501, Japan. .; Department of Drug Discovery and Biomedical Sciences, Saga University, Saga, Japan. .
Kamachi K; Division of Hematology, Respiratory Medicine and Oncology, Department of Internal Medicine, Saga University, 5-1-1 Nabeshima, Saga, 849-8501, Japan.; Department of Drug Discovery and Biomedical Sciences, Saga University, Saga, Japan.
Kimura S; Division of Hematology, Respiratory Medicine and Oncology, Department of Internal Medicine, Saga University, 5-1-1 Nabeshima, Saga, 849-8501, Japan.; Department of Drug Discovery and Biomedical Sciences, Saga University, Saga, Japan.
Pokaż więcej
Źródło :
International journal of hematology [Int J Hematol] 2020 Jun; Vol. 111 (6), pp. 903. Date of Electronic Publication: 2020 Mar 21.
Typ publikacji :
Letter
Journal Info :
Publisher: Springer Japan Country of Publication: Japan NLM ID: 9111627 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1865-3774 (Electronic) Linking ISSN: 09255710 NLM ISO Abbreviation: Int. J. Hematol. Subsets: MEDLINE
MeSH Terms :
Disease-Free Survival*
Remission Induction*
Sex Characteristics*
Leukemia, Myelogenous, Chronic, BCR-ABL Positive/*drug therapy
Female ; Humans ; Male ; Prognosis
Opinia redakcyjna
Tytuł :
A novel, more reliable approach to use of progression-free survival as a predictor of gain in overall survival: The Ottawa PFS Predictive Model.
Autorzy :
Stewart DJ; University of Ottawa and the Ottawa Hospital, 501 Smyth Road, Ottawa, ON, K1H 8L6, Canada. Electronic address: .
Bossé D; University of Ottawa and the Ottawa Hospital, 501 Smyth Road, Ottawa, ON, K1H 8L6, Canada. Electronic address: .
Goss G; University of Ottawa and the Ottawa Hospital, 501 Smyth Road, Ottawa, ON, K1H 8L6, Canada. Electronic address: .
Hilton JF; University of Ottawa and the Ottawa Hospital, 501 Smyth Road, Ottawa, ON, K1H 8L6, Canada. Electronic address: .
Jonker D; University of Ottawa and the Ottawa Hospital, 501 Smyth Road, Ottawa, ON, K1H 8L6, Canada. Electronic address: .
Fung-Kee-Fung M; University of Ottawa and the Ottawa Hospital, 501 Smyth Road, Ottawa, ON, K1H 8L6, Canada. Electronic address: .
Pokaż więcej
Źródło :
Critical reviews in oncology/hematology [Crit Rev Oncol Hematol] 2020 Apr; Vol. 148, pp. 102896. Date of Electronic Publication: 2020 Feb 08.
Typ publikacji :
Journal Article; Review
Journal Info :
Publisher: Elsevier Scientific Publishers Country of Publication: Netherlands NLM ID: 8916049 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0461 (Electronic) Linking ISSN: 10408428 NLM ISO Abbreviation: Crit. Rev. Oncol. Hematol. Subsets: MEDLINE
MeSH Terms :
Disease-Free Survival*
Progression-Free Survival*
Randomized Controlled Trials as Topic*
Antineoplastic Agents/*therapeutic use
Neoplasms/*mortality
Disease Progression ; Humans ; Medical Oncology ; Neoplasm Recurrence, Local/mortality ; Neoplasms/drug therapy ; Neoplasms/pathology ; Proportional Hazards Models ; Survival Analysis
Czasopismo naukowe
Tytuł :
Disease-free survival as a surrogate for overall survival in neoadjuvant trials of gastroesophageal adenocarcinoma: Pooled analysis of individual patient data from randomised controlled trials.
Autorzy :
Ronellenfitsch U; Medical Faculty of the Martin Luther University Halle-Wittenberg and University Hospital Halle (Saale), Department of Visceral, Vascular and Endocrine Surgery, Ernst-Grube-Str. 40, 06120, Halle (Saale), Germany. Electronic address: .
Jensen K; Institute of Medical Biometry and Informatics, University of Heidelberg, Im Neuenheimer Feld 130.3, 69120, Heidelberg, Germany. Electronic address: .
Seide S; Institute of Medical Biometry and Informatics, University of Heidelberg, Im Neuenheimer Feld 130.3, 69120, Heidelberg, Germany. Electronic address: .
Kieser M; Institute of Medical Biometry and Informatics, University of Heidelberg, Im Neuenheimer Feld 130.3, 69120, Heidelberg, Germany. Electronic address: .
Schwarzbach M; Department of General, Visceral, Vascular, and Thoracic Surgery, Klinikum Frankfurt Höchst, Gotenstraβe 6-8, 65929, Frankfurt am Main, Germany. Electronic address: .
Slanger TE; Institute for Quality and Efficiency in Health Care (IQWiG), Im Mediapark 8, 50670, Cologne, Germany. Electronic address: .
Burmeister B; University of Queensland, Princess Alexandra Hospital, Brisbane, Australia, Princess Alexandra Hospital, Brisbane, QLD, 4102, Australia. Electronic address: .
Kelsen D; Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, 1275 York Avenue, New York, NY, 10065, USA. Electronic address: .
Niedzwiecki D; The Alliance for Clinical Trials in Oncology (Alliance) Statistics and Data Center, Duke University Medical Center, Hock Plaza, 2424 Erwin Rd, Room 8040, Durham, NC, 27705, USA. Electronic address: .
Piessen G; Department of Digestive and Oncological Surgery, University Hospital C. Huriez, Inserm UMR-S 1172, Jean-Pierre Aubert Research Center (JPARC) Team, 1, Rue Polonovski, 59037, Lille Cedex, France. Electronic address: .
Schuhmacher C; Department of Surgery, Klinikum Rechts der Isar, Technical University Munich, Ismaninger Str. 22, 81675, Munich, Germany. Electronic address: .
Urba S; Division of Hematology/Oncology, University of Michigan Medical Center, 1500 E Medical Center Drive, C347, SPC 5848 Ann Arbor, MI, 48109, USA. Electronic address: .
van de Velde C; Department of Surgery, Leiden University Medical Center, K6-R, P.O. Box 9600, 2300, RC Leiden, the Netherlands. Electronic address: .
Ychou M; Centre Régional de Lutte Contre le Cancer, Val D'Aurelle, Montpellier Cedex 05, France. Electronic address: .
Hofheinz R; Day Treatment Center (TTZ), Interdisciplinary Tumor Center Mannheim (ITM) & 3rd Department of Medicine, University Medical Centre Mannheim, Medical Faculty Mannheim of the University of Heidelberg, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany. Electronic address: .
Lorenzen S; 3rd Department of Internal Medicine (Hematology/Medical Oncology), Klinikum Rechts der Isar, Technische Universität München, Ismaninger Str. 22, 81675, Munich, Germany. Electronic address: .
Pokaż więcej
Źródło :
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2019 Dec; Vol. 123, pp. 101-111. Date of Electronic Publication: 2019 Nov 01.
Typ publikacji :
Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't
Journal Info :
Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur. J. Cancer Subsets: MEDLINE
MeSH Terms :
Digestive System Surgical Procedures*
Disease-Free Survival*
Neoadjuvant Therapy*
Survival Rate*
Adenocarcinoma/*therapy
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
Chemoradiotherapy/*methods
Esophageal Neoplasms/*therapy
Stomach Neoplasms/*therapy
Adenocarcinoma/pathology ; Adult ; Aged ; Aged, 80 and over ; Biomarkers ; Esophageal Neoplasms/pathology ; Female ; Humans ; Male ; Middle Aged ; Proportional Hazards Models ; Stomach Neoplasms/pathology ; Treatment Outcome ; Young Adult
Czasopismo naukowe
Tytuł :
Assessment of Progression-Free Survival as a Surrogate End Point of Overall Survival in First-Line Treatment of Ovarian Cancer: A Systematic Review and Meta-analysis.
Autorzy :
Paoletti X; Groupe d'investigateurs national des Etudes des Cancers Ovariens (GINECO), Paris, France.; Gustave Roussy Cancer Center and Institut National de la Santé et de la Recherche Medicale Oncostat, Villejuif, France.; Department of Biostatistics, University of Versailles St Quentin, Institut Curie, Saint-Cloud, France.
Lewsley LA; Scottish Gynaecological Cancer Trials Group (SGCTG), Cancer Research United Kingdom Clinical Trial Unit, Institute of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom.
Daniele G; Multicenter Italian Trials in Ovarian Cancer and Gynecologic Malignancies (MITO), Clinical Trials Unit, Istituto Nazionale Tumori- Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Fondazione G. Pascale, Napoli, Italia.
Cook A; Medical Research Counsel Clinical Trials Unit, University College London, London, United Kingdom.
Yanaihara N; Japanese Gynecologic Oncology Group (JGOG), Jikei University School of Medicine, Tokyo, Japan.
Tinker A; Canadian Cancer Trials Group (CCTG), University of British Columbia, Vancouver, British Columbia, Canada.
Kristensen G; Nordic Society of Gynaecological Oncology, Norwegian Radium Hospital, Oslo, Norway.
Ottevanger PB; European Organisation for Research and Treatment of Cancer, Radboud University Medical Center, Nijmegen, the Netherlands.
Aravantinos G; Hellenic Cooperative Oncology Group, General Oncology Hospital of Kifissia, Nea Kifissia, Greece.
Miller A; Gynecologic Oncology Group (GOG), Roswell Park Comprehensive Cancer Center, Buffalo, New York.
Boere IA; Department of Medical Oncology, Erasmus Medical Center Cancer Institute, Rotterdam, the Netherlands.
Fruscio R; University of Milan Bicocca, San Gerardo Hospital, Monza, Italy.
Reyners AKL; University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
Pujade-Lauraine E; Association de Recherche sur les Cancers dont Gynécologiques-GINECO, Université Paris Descartes, Assistance Publique-Hôpitaux de Paris, Paris, France.
Harkin A; Scottish Gynaecological Cancer Trials Group (SGCTG), Cancer Research United Kingdom Clinical Trial Unit, Institute of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom.
Pignata S; MITO, Istituto Nazionale Tumori di Napoli IRCCS Fondazione G Pascale, Napoli, Italy.
Kagimura T; JGOG, Foundation for Biomedical Research and Innovation at Kobe, Translational Research Center for Medical Innovation, Kobe, Japan.
Welch S; CCTG, London Health Sciences Centre, London, Ontario, Canada.
Paul J; Scottish Gynaecological Cancer Trials Group (SGCTG), Cancer Research United Kingdom Clinical Trial Unit, Institute of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom.
Karamouza E; Gustave Roussy Cancer Center, Villejuif, France.
Glasspool RM; SGCTG, Beatson West of Scotland Cancer Centre, NHS (National Health Service) Greater Glasgow and Clyde, Glasgow, United Kingdom.
Pokaż więcej
Corporate Authors :
Gynecologic Cancer InterGroup (GCIG) Meta-analysis Committee
Źródło :
JAMA network open [JAMA Netw Open] 2020 Jan 03; Vol. 3 (1), pp. e1918939. Date of Electronic Publication: 2020 Jan 03.
Typ publikacji :
Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't; Systematic Review
Journal Info :
Publisher: American Medical Association Country of Publication: United States NLM ID: 101729235 Publication Model: Electronic Cited Medium: Internet ISSN: 2574-3805 (Electronic) Linking ISSN: 25743805 NLM ISO Abbreviation: JAMA Netw Open Subsets: MEDLINE
MeSH Terms :
Disease-Free Survival*
Progression-Free Survival*
Ovarian Neoplasms/*mortality
Adolescent ; Adult ; Aged ; Aged, 80 and over ; Biomarkers/analysis ; Female ; Humans ; Middle Aged ; Ovarian Neoplasms/therapy ; Proportional Hazards Models ; Randomized Controlled Trials as Topic ; Young Adult
Czasopismo naukowe
Tytuł :
Elastic Net-Based Identification of a Multigene Combination Predicting the Survival of Patients with Cervical Cancer.
Autorzy :
Wang H; Department of Obstetrics and Gynecology, Xiangyang No.1 People's Hospital, Affiliated Hospital of Hubei University of Medicine, Xiangyang, Hubei, China (mainland).
Li SW; Department of Obstetrics and Gynecology, Xiangyang No.1 People's Hospital, Affiliated Hospital of Hubei University of Medicine, Xiangyang, Hubei, China (mainland).
Li W; Department of Obstetrics and Gynecology, Xiangyang No.1 People's Hospital, Affiliated Hospital of Hubei University of Medicine, Xiangyang, Hubei, China (mainland).
Cai HB; Department of Gynecologic Oncology, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China (mainland).; Hubei Cancer Clinical Study Center, Wuhan, Hubei, China (mainland).; Hubei Key Laboratory of Tumor Biological Behaviors, Wuhan, Hubei, China (mainland).
Pokaż więcej
Źródło :
Medical science monitor : international medical journal of experimental and clinical research [Med Sci Monit] 2019 Dec 29; Vol. 25, pp. 10105-10113. Date of Electronic Publication: 2019 Dec 29.
Typ publikacji :
Journal Article
Journal Info :
Publisher: International Scientific Information, Inc Country of Publication: United States NLM ID: 9609063 Publication Model: Electronic Cited Medium: Internet ISSN: 1643-3750 (Electronic) Linking ISSN: 12341010 NLM ISO Abbreviation: Med. Sci. Monit. Subsets: MEDLINE
MeSH Terms :
Disease-Free Survival*
Uterine Cervical Neoplasms/*genetics
Adult ; Aged ; Aged, 80 and over ; Area Under Curve ; Decision Making ; Female ; Gene Expression Regulation, Neoplastic ; Humans ; Middle Aged ; Multivariate Analysis ; Neoplasm Staging ; Prognosis ; Proportional Hazards Models ; ROC Curve ; Reproducibility of Results ; Risk Factors ; Uterine Cervical Neoplasms/pathology ; Young Adult
Czasopismo naukowe
Tytuł :
Hepatobiliary versus Extracellular MRI Contrast Agents in Hepatocellular Carcinoma Detection: Hepatobiliary Phase Features in Relation to Disease-free Survival.
Autorzy :
Kim DK; From the Department of Radiology, Severance Hospital, Research Institute of Radiological Science, Yonsei University College of Medicine, 50-1 Yonseiro, Seodaemun-gu, Seoul 03722, Korea.
An C; From the Department of Radiology, Severance Hospital, Research Institute of Radiological Science, Yonsei University College of Medicine, 50-1 Yonseiro, Seodaemun-gu, Seoul 03722, Korea.
Chung YE; From the Department of Radiology, Severance Hospital, Research Institute of Radiological Science, Yonsei University College of Medicine, 50-1 Yonseiro, Seodaemun-gu, Seoul 03722, Korea.
Choi JY; From the Department of Radiology, Severance Hospital, Research Institute of Radiological Science, Yonsei University College of Medicine, 50-1 Yonseiro, Seodaemun-gu, Seoul 03722, Korea.
Lim JS; From the Department of Radiology, Severance Hospital, Research Institute of Radiological Science, Yonsei University College of Medicine, 50-1 Yonseiro, Seodaemun-gu, Seoul 03722, Korea.
Park MS; From the Department of Radiology, Severance Hospital, Research Institute of Radiological Science, Yonsei University College of Medicine, 50-1 Yonseiro, Seodaemun-gu, Seoul 03722, Korea.
Kim MJ; From the Department of Radiology, Severance Hospital, Research Institute of Radiological Science, Yonsei University College of Medicine, 50-1 Yonseiro, Seodaemun-gu, Seoul 03722, Korea.
Pokaż więcej
Źródło :
Radiology [Radiology] 2019 Dec; Vol. 293 (3), pp. 594-604. Date of Electronic Publication: 2019 Oct 08.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
Journal Info :
Publisher: Radiological Society of North America Country of Publication: United States NLM ID: 0401260 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-1315 (Electronic) Linking ISSN: 00338419 NLM ISO Abbreviation: Radiology Subsets: Core Clinical (AIM); MEDLINE
MeSH Terms :
Disease-Free Survival*
Carcinoma, Hepatocellular/*diagnostic imaging
Contrast Media/*administration & dosage
Liver Neoplasms/*diagnostic imaging
Magnetic Resonance Imaging/*methods
Aged ; Carcinoma, Hepatocellular/surgery ; Female ; Humans ; Liver Neoplasms/surgery ; Male ; Middle Aged ; Retrospective Studies ; Sensitivity and Specificity
Czasopismo naukowe
Tytuł :
Tumor-Infiltrating Lymphocyte Volume Is a Better Predictor of Disease-Free Survival Than Stromal Tumor-Infiltrating Lymphocytes in Invasive Breast Carcinoma.
Autorzy :
Vaziri Fard E; Department of Pathology and Laboratory Medicine, University of Texas Health Science Center at Houston, Houston.
Ali Y; Department of Pathology and Laboratory Medicine, University of Texas Health Science Center at Houston, Houston.
Wang XI; Department of Pathology and Laboratory Medicine, University of Texas Health Science Center at Houston, Houston.
Saluja K; Department of Pathology and Laboratory Medicine, University of Texas Health Science Center at Houston, Houston.
H Covinsky M; Department of Pathology and Laboratory Medicine, University of Texas Health Science Center at Houston, Houston.
Wang L; Department of Urology, Division of Surgery, University of Texas MD Anderson Cancer Center, Houston.
Zhang S; Department of Pathology and Laboratory Medicine, University of Texas Health Science Center at Houston, Houston.
Pokaż więcej
Źródło :
American journal of clinical pathology [Am J Clin Pathol] 2019 Oct 07; Vol. 152 (5), pp. 656-665.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
Journal Info :
Publisher: Oxford University Press Country of Publication: England NLM ID: 0370470 Publication Model: Print Cited Medium: Internet ISSN: 1943-7722 (Electronic) Linking ISSN: 00029173 NLM ISO Abbreviation: Am. J. Clin. Pathol. Subsets: Core Clinical (AIM); MEDLINE
MeSH Terms :
Disease-Free Survival*
Breast Neoplasms/*mortality
Breast Neoplasms/*pathology
Lymphocytes, Tumor-Infiltrating/*pathology
Stromal Cells/*pathology
Carcinoma, Ductal, Breast/mortality ; Carcinoma, Ductal, Breast/pathology ; Carcinoma, Lobular/mortality ; Carcinoma, Lobular/pathology ; Female ; Humans ; Kaplan-Meier Estimate ; Prognosis ; Reproducibility of Results ; Triple Negative Breast Neoplasms/mortality ; Triple Negative Breast Neoplasms/pathology
Czasopismo naukowe
Tytuł :
The time to relapse correlates with the histopathological growth pattern in nodular lymphocyte predominant Hodgkin lymphoma.
Autorzy :
Hartmann S; Senckenberg Institute of Pathology, Goethe University, Frankfurt am Main, Germany.; Reference and Consultation Center for Lymph Node and Lymphoma Pathology, Goethe University, Frankfurt am Main, Germany.
Plütschow A; First Department of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Dusseldorf, University of Cologne, Cologne, Germany.; German Hodgkin Study Group, University Hospital Cologne, Cologne, Germany.
Mottok A; Institute of Pathology, University of Würzburg and Comprehensive Cancer Center (CCC) Mainfranken, Würzburg, Germany.; Institute of Human Genetics, Ulm University and Ulm University Medical Center, Ulm, Germany.
Bernd HW; Hematopathology Lübeck, Lübeck, Germany.
Feller AC; Hematopathology Lübeck, Lübeck, Germany.
Ott G; Department of Clinical Pathology, Robert-Bosch-Krankenhaus and Dr Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany.
Cogliatti S; Institute of Pathology, Kantonsspital St. Gallen, St. Gallen, Switzerland.
Fend F; Institute of Pathology, Eberhard Karls University Tübingen, Tübingen, Germany.
Quintanilla-Martinez L; Institute of Pathology, Eberhard Karls University Tübingen, Tübingen, Germany.
Stein H; Pathodiagnostic Berlin, Berlin Reference Center for Lymphoma and Hematopathology, Berlin, Germany.
Klapper W; Institute of Pathology, Hematopathology Section and Lymph Node Registry, University Hospital Schleswig-Holstein Campus Kiel, Kiel, Germany.
Möller P; Institute of Pathology, University Hospital Ulm, Ulm, Germany.
Rosenwald A; Institute of Pathology, University of Würzburg and Comprehensive Cancer Center (CCC) Mainfranken, Würzburg, Germany.
Engert A; First Department of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Dusseldorf, University of Cologne, Cologne, Germany.; German Hodgkin Study Group, University Hospital Cologne, Cologne, Germany.
Hansmann ML; Senckenberg Institute of Pathology, Goethe University, Frankfurt am Main, Germany.; Reference and Consultation Center for Lymph Node and Lymphoma Pathology, Goethe University, Frankfurt am Main, Germany.; Frankfurt Institute of Advanced Studies, Frankfurt am Main, Germany.
Eichenauer DA; First Department of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Dusseldorf, University of Cologne, Cologne, Germany.; German Hodgkin Study Group, University Hospital Cologne, Cologne, Germany.
Pokaż więcej
Źródło :
American journal of hematology [Am J Hematol] 2019 Nov; Vol. 94 (11), pp. 1208-1213. Date of Electronic Publication: 2019 Aug 21.
Typ publikacji :
Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
Journal Info :
Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 7610369 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-8652 (Electronic) Linking ISSN: 03618609 NLM ISO Abbreviation: Am. J. Hematol. Subsets: MEDLINE
MeSH Terms :
Disease-Free Survival*
Hodgkin Disease/*pathology
Adult ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Biopsy ; Combined Modality Therapy ; Female ; Follow-Up Studies ; Germany/epidemiology ; Hematopoietic Stem Cell Transplantation ; Hodgkin Disease/drug therapy ; Hodgkin Disease/epidemiology ; Hodgkin Disease/radiotherapy ; Humans ; Male ; Recurrence ; Rituximab/therapeutic use ; Transplantation, Autologous
Czasopismo naukowe
Tytuł :
Assessment of Survival of Pediatric Patients With Hepatoblastoma Who Received Chemotherapy Following Liver Transplant or Liver Resection.
Autorzy :
Feng J; Institute of Organ Transplantation, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.; Department of Surgery, University of Heidelberg, Heidelberg, Germany.
He Y; Department of Liver Surgery, Liver Transplantation Center, West China Hospital of Sichuan University, Chengdu, Sichuan Province, China.
Wei L; Institute of Organ Transplantation, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Chen D; Institute of Organ Transplantation, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Yang H; Institute of Organ Transplantation, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Tan R; Institute of Organ Transplantation, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Chen Z; Institute of Organ Transplantation, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Pokaż więcej
Źródło :
JAMA network open [JAMA Netw Open] 2019 Oct 02; Vol. 2 (10), pp. e1912676. Date of Electronic Publication: 2019 Oct 02.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
Journal Info :
Publisher: American Medical Association Country of Publication: United States NLM ID: 101729235 Publication Model: Electronic Cited Medium: Internet ISSN: 2574-3805 (Electronic) Linking ISSN: 25743805 NLM ISO Abbreviation: JAMA Netw Open Subsets: MEDLINE
MeSH Terms :
Disease-Free Survival*
Antineoplastic Agents/*therapeutic use
Hepatoblastoma/*drug therapy
Hepatoblastoma/*mortality
Liver/*surgery
Liver Transplantation/*mortality
Child, Preschool ; Female ; Hepatoblastoma/surgery ; Humans ; Infant ; Liver/pathology ; Logistic Models ; Male ; Pediatrics ; Proportional Hazards Models ; Registries ; Survival ; United States/epidemiology
Czasopismo naukowe
Tytuł :
The role of radiotherapy in metaplastic breast cancer: a propensity score-matched analysis of the SEER database.
Autorzy :
Li Y; Department of Breast Surgery, Institute of Cancer and Basic Medicine (ICBM), Chinese Academy of Science; Cancer Hospital of the University of Chinese Academy of Sciences; Zhejiang Cancer Hospital, Hangzhou, 310022, Zhejiang, People's Republic of China.; Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, South Campus Research Building 4, 1901 East Road, Houston, TX, 77054, USA.
Chen M; Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, South Campus Research Building 4, 1901 East Road, Houston, TX, 77054, USA.
Pardini B; Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, South Campus Research Building 4, 1901 East Road, Houston, TX, 77054, USA.; Italian Institute for Genomic Medicine, Turin, Italy.
Dragomir MP; Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, South Campus Research Building 4, 1901 East Road, Houston, TX, 77054, USA. .; Department of Surgery, Fundeni Clinical Hospital, 22328, Bucharest, Romania. .; The Research Center for Functional Genomics, Biomedicine and Translational Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, 400012, Cluj Napoca, Romania. .
Lucci A; Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, 1400 Pressler St, Unit 1484, Houston, TX, 77030, USA. .
Calin GA; Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, South Campus Research Building 4, 1901 East Road, Houston, TX, 77054, USA. .; Center for RNA Interference and Non-coding RNAs, The University of Texas MD Anderson Cancer Center, Houston, TX, 77054, USA. .
Pokaż więcej
Źródło :
Journal of translational medicine [J Transl Med] 2019 Sep 23; Vol. 17 (1), pp. 318. Date of Electronic Publication: 2019 Sep 23.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
Journal Info :
Publisher: BioMed Central Country of Publication: England NLM ID: 101190741 Publication Model: Electronic Cited Medium: Internet ISSN: 1479-5876 (Electronic) Linking ISSN: 14795876 NLM ISO Abbreviation: J Transl Med Subsets: MEDLINE
MeSH Terms :
Databases, Factual*
Disease-Free Survival*
Propensity Score*
SEER Program*
Breast Neoplasms/*epidemiology
Breast Neoplasms/*radiotherapy
Breast Neoplasms/pathology ; Female ; Humans ; Kaplan-Meier Estimate ; Middle Aged ; Multivariate Analysis ; Neoplasm Metastasis
Czasopismo naukowe
Tytuł :
Long-term follow-up of a novel immunosuppressive strategy of cyclosporine alternatively combined with levamisole for severe aplastic anemia.
Autorzy :
Huo J; State Key Laboratory of Experimental Hematology, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Science & Peking Union Medical College, 288 Nanjing Road, Tianjin, 300020, People's Republic of China.
Li X; State Key Laboratory of Experimental Hematology, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Science & Peking Union Medical College, 288 Nanjing Road, Tianjin, 300020, People's Republic of China.
Shao Y; State Key Laboratory of Experimental Hematology, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Science & Peking Union Medical College, 288 Nanjing Road, Tianjin, 300020, People's Republic of China.
Ren X; State Key Laboratory of Experimental Hematology, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Science & Peking Union Medical College, 288 Nanjing Road, Tianjin, 300020, People's Republic of China.
Ge M; State Key Laboratory of Experimental Hematology, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Science & Peking Union Medical College, 288 Nanjing Road, Tianjin, 300020, People's Republic of China.
You Y; State Key Laboratory of Experimental Hematology, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Science & Peking Union Medical College, 288 Nanjing Road, Tianjin, 300020, People's Republic of China.
Huang J; State Key Laboratory of Experimental Hematology, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Science & Peking Union Medical College, 288 Nanjing Road, Tianjin, 300020, People's Republic of China.
Zhang J; State Key Laboratory of Experimental Hematology, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Science & Peking Union Medical College, 288 Nanjing Road, Tianjin, 300020, People's Republic of China.
Wang M; State Key Laboratory of Experimental Hematology, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Science & Peking Union Medical College, 288 Nanjing Road, Tianjin, 300020, People's Republic of China.
Nie N; State Key Laboratory of Experimental Hematology, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Science & Peking Union Medical College, 288 Nanjing Road, Tianjin, 300020, People's Republic of China.
Jin P; State Key Laboratory of Experimental Hematology, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Science & Peking Union Medical College, 288 Nanjing Road, Tianjin, 300020, People's Republic of China.
Zheng Y; State Key Laboratory of Experimental Hematology, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Science & Peking Union Medical College, 288 Nanjing Road, Tianjin, 300020, People's Republic of China. .
Pokaż więcej
Źródło :
Annals of hematology [Ann Hematol] 2020 Aug; Vol. 99 (8), pp. 1727-1734. Date of Electronic Publication: 2020 Jun 29.
Typ publikacji :
Clinical Trial; Journal Article
Journal Info :
Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9107334 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0584 (Electronic) Linking ISSN: 09395555 NLM ISO Abbreviation: Ann. Hematol. Subsets: MEDLINE
MeSH Terms :
Immunosuppression*
Anemia, Aplastic/*drug therapy
Anemia, Aplastic/*mortality
Cyclosporine/*administration & dosage
Levamisole/*administration & dosage
Adolescent ; Adult ; Aged ; Child ; Child, Preschool ; Developing Countries ; Disease-Free Survival ; Female ; Follow-Up Studies ; Humans ; Male ; Middle Aged ; Severity of Illness Index ; Survival Rate
Czasopismo naukowe
Tytuł :
Clinical characteristics and treatment outcome of type I cryoglobulinemia in Chinese patients: a single-center study of 45 patients.
Autorzy :
Zhang LL; Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No. 1 Shuaifuyuan, ,100730, Beijing, People's Republic of China.
Cao XX; Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No. 1 Shuaifuyuan, ,100730, Beijing, People's Republic of China.
Shen KN; Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No. 1 Shuaifuyuan, ,100730, Beijing, People's Republic of China.
Han HX; Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No. 1 Shuaifuyuan, ,100730, Beijing, People's Republic of China.
Zhang CL; Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No. 1 Shuaifuyuan, ,100730, Beijing, People's Republic of China.
Qiu Y; Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No. 1 Shuaifuyuan, ,100730, Beijing, People's Republic of China.
Zhao H; Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No. 1 Shuaifuyuan, ,100730, Beijing, People's Republic of China.
Gao XM; Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No. 1 Shuaifuyuan, ,100730, Beijing, People's Republic of China.
Feng J; Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No. 1 Shuaifuyuan, ,100730, Beijing, People's Republic of China.
Zhang L; Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No. 1 Shuaifuyuan, ,100730, Beijing, People's Republic of China.
Zhou DB; Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No. 1 Shuaifuyuan, ,100730, Beijing, People's Republic of China.
Li J; Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No. 1 Shuaifuyuan, ,100730, Beijing, People's Republic of China. .
Pokaż więcej
Źródło :
Annals of hematology [Ann Hematol] 2020 Aug; Vol. 99 (8), pp. 1735-1740. Date of Electronic Publication: 2020 Jun 13.
Typ publikacji :
Journal Article
Journal Info :
Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9107334 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0584 (Electronic) Linking ISSN: 09395555 NLM ISO Abbreviation: Ann. Hematol. Subsets: MEDLINE
MeSH Terms :
Bortezomib/*administration & dosage
Cryoglobulinemia/*drug therapy
Cryoglobulinemia/*mortality
Rituximab/*administration & dosage
Adult ; Aged ; Aged, 80 and over ; Asian Continental Ancestry Group ; China/epidemiology ; Cryoglobulinemia/blood ; Cryoglobulinemia/pathology ; Disease-Free Survival ; Female ; Humans ; Male ; Middle Aged ; Survival Rate
Czasopismo naukowe
Tytuł :
Necrotizing fasciitis in haematological patients: a different scenario.
Autorzy :
Albasanz-Puig A; Infectious Diseases Department, Hospital Universitari Vall d'Hebron, Vall d'Hebron Institut de Recerca, Universitat Autònoma de Barcelona, Department of Medicine, Pg. Vall d'Hebron 119-129, 08035, Barcelona, Spain.; Spanish Network for Research in Infectious Pathology (REIPI), Instituto de Salud Carlos III, Madrid, Spain.
Rodríguez-Pardo D; Infectious Diseases Department, Hospital Universitari Vall d'Hebron, Vall d'Hebron Institut de Recerca, Universitat Autònoma de Barcelona, Department of Medicine, Pg. Vall d'Hebron 119-129, 08035, Barcelona, Spain. .; Spanish Network for Research in Infectious Pathology (REIPI), Instituto de Salud Carlos III, Madrid, Spain. .
Pigrau C; Infectious Diseases Department, Hospital Universitari Vall d'Hebron, Vall d'Hebron Institut de Recerca, Universitat Autònoma de Barcelona, Department of Medicine, Pg. Vall d'Hebron 119-129, 08035, Barcelona, Spain.; Spanish Network for Research in Infectious Pathology (REIPI), Instituto de Salud Carlos III, Madrid, Spain.
Lung M; Microbiology Department, Hospital Universitari Vall d'Hebron, Vall d'Hebron Institut de Recerca, Universitat Autònoma de Barcelona, Barcelona, Spain.
Roldan E; Haematology Department, Hospital Universitari Vall d'Hebron, Vall d'Hebron Institut de Recerca, Universitat Autònoma de Barcelona, Barcelona, Spain.
Corona PS; Spanish Network for Research in Infectious Pathology (REIPI), Instituto de Salud Carlos III, Madrid, Spain.; Reconstructive and Septic Surgery Division, Department of Orthopedic Surgery, Hospital Universitari Vall d'Hebron, Vall d'Hebron Institut de Recerca, Universitat Autònoma de Barcelona, Barcelona, Spain.
Almirante B; Infectious Diseases Department, Hospital Universitari Vall d'Hebron, Vall d'Hebron Institut de Recerca, Universitat Autònoma de Barcelona, Department of Medicine, Pg. Vall d'Hebron 119-129, 08035, Barcelona, Spain.; Spanish Network for Research in Infectious Pathology (REIPI), Instituto de Salud Carlos III, Madrid, Spain.
Ruiz-Camps I; Infectious Diseases Department, Hospital Universitari Vall d'Hebron, Vall d'Hebron Institut de Recerca, Universitat Autònoma de Barcelona, Department of Medicine, Pg. Vall d'Hebron 119-129, 08035, Barcelona, Spain.; Spanish Network for Research in Infectious Pathology (REIPI), Instituto de Salud Carlos III, Madrid, Spain.
Pokaż więcej
Źródło :
Annals of hematology [Ann Hematol] 2020 Aug; Vol. 99 (8), pp. 1741-1747. Date of Electronic Publication: 2020 May 12.
Typ publikacji :
Journal Article
Journal Info :
Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9107334 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0584 (Electronic) Linking ISSN: 09395555 NLM ISO Abbreviation: Ann. Hematol. Subsets: MEDLINE
MeSH Terms :
Escherichia coli*
Neutropenia*/microbiology
Neutropenia*/therapy
Escherichia coli Infections/*mortality
Fasciitis, Necrotizing/*mortality
Hematologic Neoplasms/*mortality
Adult ; Aged ; Disease-Free Survival ; Escherichia coli Infections/therapy ; Fasciitis, Necrotizing/microbiology ; Fasciitis, Necrotizing/therapy ; Female ; Hematologic Neoplasms/microbiology ; Hematologic Neoplasms/therapy ; Humans ; Male ; Middle Aged ; Retrospective Studies ; Spain/epidemiology ; Survival Rate
Czasopismo naukowe
Tytuł :
Safety and efficacy of temsirolimus in combination with three different immuno-chemotherapy regimens in relapse and refractory mantle cell lymphoma, final results of the T phase IB trial of the LYSA.
Autorzy :
Tessoulin B; Department of Hematology, CHU de Nantes, University Hospital of Nantes, Nantes, France.; INSERM, UMR892, Equipe 10, Nantes, France.
Bouabdallah K; Haematology, CHU de Bordeaux, Bordeaux, France.
Burroni B; Pathology Department, Cochin University Hospital, AP-HP, Paris, France.
Lamy T; INSERM U917, CHU Pontchaillou, Rennes, France.
Gressin R; Hematology, CHU Grenoble, Grenoble, Grenoble, France.
Cartron G; Department of clinical hematology, University Hospital Montpellier, Montpellier, France.
Thieblemont C; Hôpital Saint-Louis, Paris, France.
Sarkozy C; Hematology, Hospices Civils de Lyon, Pierre Bénite, Lyon, France.
Haioun C; Lymphoid Malignancies Unit, AP-HP, Groupe Hospitalier Mondor, Croéteil, France.
Casasnovas O; Hematology Department, Hopital Le Bocage, CHU Dijon, Dijon, France.
Joubert C; Department of Biostatistics, LYSARC, Lyon, France.
Gyan E; Service d'Hématologie et thérapie cellulaire, Centre Hospitalier Universitaire, Tours, France.
Hermine O; Hematology Department, Necker University Hospital, AP-HP, Paris, France.
Le Gouill S; Department of Hematology, CHU de Nantes, University Hospital of Nantes, Nantes, France. .; INSERM, UMR892, Equipe 10, Nantes, France. .; INSERM, CIC 004, Nantes University Hospital, Nantes, France. .
Pokaż więcej
Źródło :
Annals of hematology [Ann Hematol] 2020 Aug; Vol. 99 (8), pp. 1771-1778. Date of Electronic Publication: 2020 Jun 29.
Typ publikacji :
Clinical Trial, Phase I; Journal Article; Multicenter Study
Journal Info :
Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9107334 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0584 (Electronic) Linking ISSN: 09395555 NLM ISO Abbreviation: Ann. Hematol. Subsets: MEDLINE
MeSH Terms :
Immunotherapy*
Antineoplastic Combined Chemotherapy Protocols/*administration & dosage
Lymphoma, Mantle-Cell/*therapy
Sirolimus/*analogs & derivatives
Aged ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Cyclophosphamide/administration & dosage ; Cyclophosphamide/adverse effects ; Disease-Free Survival ; Doxorubicin/administration & dosage ; Doxorubicin/adverse effects ; Female ; Humans ; Lymphoma, Mantle-Cell/mortality ; Male ; Middle Aged ; Prednisone/administration & dosage ; Prednisone/adverse effects ; Rituximab/administration & dosage ; Rituximab/adverse effects ; Sirolimus/administration & dosage ; Sirolimus/adverse effects ; Survival Rate ; Thrombocytopenia/chemically induced ; Thrombocytopenia/mortality ; Vincristine/administration & dosage ; Vincristine/adverse effects
Czasopismo naukowe
Tytuł :
The expression and prognostic role of EBP1 and relationship with AR in HER2+ breast cancer.
Autorzy :
Liu J; Department of Breast Cancer Pathology and Research Laboratory, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.; National Clinical Research Center for Cancer,Tianjin Medical University Cancer Institute and Hospital, West Huanhu Road, Ti Yuan Bei, Hexi District, Tianjin, 300060, China.; Key Laboratory of Cancer Prevention and Therapy,Tianjin, West Huanhu Road, Ti Yuan Bei, Hexi District, Tianjin, 300060, Tianjin, China.; Tianjin's Clinical Research Center for Cancer, West Huanhu Road, Ti Yuan Bei, Hexi District, Tianjin, 300060, China.; Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, West Huanhu Road, Ti Yuan Bei, Hexi District, Tianjin, 300060, China.
Xu C; Department of Breast Cancer Pathology and Research Laboratory, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.; National Clinical Research Center for Cancer,Tianjin Medical University Cancer Institute and Hospital, West Huanhu Road, Ti Yuan Bei, Hexi District, Tianjin, 300060, China.; Key Laboratory of Cancer Prevention and Therapy,Tianjin, West Huanhu Road, Ti Yuan Bei, Hexi District, Tianjin, 300060, Tianjin, China.; Tianjin's Clinical Research Center for Cancer, West Huanhu Road, Ti Yuan Bei, Hexi District, Tianjin, 300060, China.; Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, West Huanhu Road, Ti Yuan Bei, Hexi District, Tianjin, 300060, China.
Xu D; Department of Breast Cancer Pathology and Research Laboratory, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.; National Clinical Research Center for Cancer,Tianjin Medical University Cancer Institute and Hospital, West Huanhu Road, Ti Yuan Bei, Hexi District, Tianjin, 300060, China.; Key Laboratory of Cancer Prevention and Therapy,Tianjin, West Huanhu Road, Ti Yuan Bei, Hexi District, Tianjin, 300060, Tianjin, China.; Tianjin's Clinical Research Center for Cancer, West Huanhu Road, Ti Yuan Bei, Hexi District, Tianjin, 300060, China.; Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, West Huanhu Road, Ti Yuan Bei, Hexi District, Tianjin, 300060, China.
Cao L; Department of Breast Cancer Pathology and Research Laboratory, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.; National Clinical Research Center for Cancer,Tianjin Medical University Cancer Institute and Hospital, West Huanhu Road, Ti Yuan Bei, Hexi District, Tianjin, 300060, China.; Key Laboratory of Cancer Prevention and Therapy,Tianjin, West Huanhu Road, Ti Yuan Bei, Hexi District, Tianjin, 300060, Tianjin, China.; Tianjin's Clinical Research Center for Cancer, West Huanhu Road, Ti Yuan Bei, Hexi District, Tianjin, 300060, China.; Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, West Huanhu Road, Ti Yuan Bei, Hexi District, Tianjin, 300060, China.
Xue H; Department of Breast Cancer Pathology and Research Laboratory, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.; National Clinical Research Center for Cancer,Tianjin Medical University Cancer Institute and Hospital, West Huanhu Road, Ti Yuan Bei, Hexi District, Tianjin, 300060, China.; Key Laboratory of Cancer Prevention and Therapy,Tianjin, West Huanhu Road, Ti Yuan Bei, Hexi District, Tianjin, 300060, Tianjin, China.; Tianjin's Clinical Research Center for Cancer, West Huanhu Road, Ti Yuan Bei, Hexi District, Tianjin, 300060, China.; Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, West Huanhu Road, Ti Yuan Bei, Hexi District, Tianjin, 300060, China.
Meng Q; Department of Breast Cancer Pathology and Research Laboratory, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.; National Clinical Research Center for Cancer,Tianjin Medical University Cancer Institute and Hospital, West Huanhu Road, Ti Yuan Bei, Hexi District, Tianjin, 300060, China.; Key Laboratory of Cancer Prevention and Therapy,Tianjin, West Huanhu Road, Ti Yuan Bei, Hexi District, Tianjin, 300060, Tianjin, China.; Tianjin's Clinical Research Center for Cancer, West Huanhu Road, Ti Yuan Bei, Hexi District, Tianjin, 300060, China.; Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, West Huanhu Road, Ti Yuan Bei, Hexi District, Tianjin, 300060, China.
Niu Y; Department of Breast Cancer Pathology and Research Laboratory, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China. .; National Clinical Research Center for Cancer,Tianjin Medical University Cancer Institute and Hospital, West Huanhu Road, Ti Yuan Bei, Hexi District, Tianjin, 300060, China. .; Key Laboratory of Cancer Prevention and Therapy,Tianjin, West Huanhu Road, Ti Yuan Bei, Hexi District, Tianjin, 300060, Tianjin, China. .; Tianjin's Clinical Research Center for Cancer, West Huanhu Road, Ti Yuan Bei, Hexi District, Tianjin, 300060, China. .; Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, West Huanhu Road, Ti Yuan Bei, Hexi District, Tianjin, 300060, China. .
Pokaż więcej
Źródło :
Virchows Archiv : an international journal of pathology [Virchows Arch] 2020 Aug; Vol. 477 (2), pp. 279-289. Date of Electronic Publication: 2020 Feb 21.
Typ publikacji :
Journal Article
Journal Info :
Publisher: Springer International Country of Publication: Germany NLM ID: 9423843 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-2307 (Electronic) Linking ISSN: 09456317 NLM ISO Abbreviation: Virchows Arch. Subsets: MEDLINE
MeSH Terms :
Adaptor Proteins, Signal Transducing/*metabolism
Breast Neoplasms/*pathology
RNA-Binding Proteins/*metabolism
Receptor, ErbB-2/*metabolism
Receptors, Androgen/*metabolism
Adult ; Biomarkers, Tumor/analysis ; Breast Neoplasms/metabolism ; Disease-Free Survival ; Female ; Gene Expression Regulation, Neoplastic/genetics ; Humans ; Middle Aged ; Receptors, Estrogen/metabolism ; Receptors, Progesterone
Czasopismo naukowe
Tytuł :
Pre-transplant FLT3/ITD status predicts outcome in FLT3-mutated acute myeloid leukemia following allogeneic stem cell transplantation.
Autorzy :
Helbig G; Department of Hematology and Bone Marrow Transplantation, School of Medicine in Katowice, Medical University of Silesia, Dąbrowski street 25, 40-032, Katowice, Poland. .
Koclęga A; Department of Hematology and Bone Marrow Transplantation, School of Medicine in Katowice, Medical University of Silesia, Dąbrowski street 25, 40-032, Katowice, Poland.
Wieczorkiewicz-Kabut A; Department of Hematology and Bone Marrow Transplantation, School of Medicine in Katowice, Medical University of Silesia, Dąbrowski street 25, 40-032, Katowice, Poland.
Woźniczka K; Department of Hematology and Bone Marrow Transplantation, School of Medicine in Katowice, Medical University of Silesia, Dąbrowski street 25, 40-032, Katowice, Poland.
Kopińska A; Department of Hematology and Bone Marrow Transplantation, School of Medicine in Katowice, Medical University of Silesia, Dąbrowski street 25, 40-032, Katowice, Poland.
Boral K; Department of Hematology and Bone Marrow Transplantation, School of Medicine in Katowice, Medical University of Silesia, Dąbrowski street 25, 40-032, Katowice, Poland.
Grygoruk-Wiśniowska I; Department of Hematology and Bone Marrow Transplantation, School of Medicine in Katowice, Medical University of Silesia, Dąbrowski street 25, 40-032, Katowice, Poland.
Stachowicz M; Department of Hematology and Bone Marrow Transplantation, School of Medicine in Katowice, Medical University of Silesia, Dąbrowski street 25, 40-032, Katowice, Poland.
Karolczyk A; Department of Hematology and Bone Marrow Transplantation, School of Medicine in Katowice, Medical University of Silesia, Dąbrowski street 25, 40-032, Katowice, Poland.
Pokaż więcej
Źródło :
Annals of hematology [Ann Hematol] 2020 Aug; Vol. 99 (8), pp. 1845-1853. Date of Electronic Publication: 2020 Apr 24.
Typ publikacji :
Clinical Trial; Journal Article
Journal Info :
Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9107334 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0584 (Electronic) Linking ISSN: 09395555 NLM ISO Abbreviation: Ann. Hematol. Subsets: MEDLINE
MeSH Terms :
Mutation*
Stem Cell Transplantation*
Unrelated Donors*
Antineoplastic Combined Chemotherapy Protocols/*administration & dosage
Leukemia, Myeloid, Acute/*therapy
fms-Like Tyrosine Kinase 3/*genetics
Adult ; Aged ; Allografts ; Disease-Free Survival ; Female ; Follow-Up Studies ; Humans ; Leukemia, Myeloid, Acute/genetics ; Leukemia, Myeloid, Acute/mortality ; Male ; Middle Aged ; Predictive Value of Tests ; Survival Rate
Czasopismo naukowe
Tytuł :
Serum-free light chains combined with the Revised International Staging System could further distinguish the superior and inferior clinical outcome of multiple myeloma patients.
Autorzy :
Du J; Department of Hematology, The Myeloma & Lymphoma Center, Shanghai Changzheng Hospital, The Second Military Medical University, 415 Fengyang Rd, Shanghai, 200003, China. .
Lu J; Department of Hematology, The Myeloma & Lymphoma Center, Shanghai Changzheng Hospital, The Second Military Medical University, 415 Fengyang Rd, Shanghai, 200003, China.
Gao W; Department of Hematology, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China.
Liu J; Department of Hematology, The Myeloma & Lymphoma Center, Shanghai Changzheng Hospital, The Second Military Medical University, 415 Fengyang Rd, Shanghai, 200003, China.
He H; Department of Hematology, The Myeloma & Lymphoma Center, Shanghai Changzheng Hospital, The Second Military Medical University, 415 Fengyang Rd, Shanghai, 200003, China.
Li L; Department of Hematology, The Myeloma & Lymphoma Center, Shanghai Changzheng Hospital, The Second Military Medical University, 415 Fengyang Rd, Shanghai, 200003, China.
Li R; Department of Hematology, The Myeloma & Lymphoma Center, Shanghai Changzheng Hospital, The Second Military Medical University, 415 Fengyang Rd, Shanghai, 200003, China.
Zhou L; Department of Hematology, The Myeloma & Lymphoma Center, Shanghai Changzheng Hospital, The Second Military Medical University, 415 Fengyang Rd, Shanghai, 200003, China.
Jiang H; Department of Hematology, The Myeloma & Lymphoma Center, Shanghai Changzheng Hospital, The Second Military Medical University, 415 Fengyang Rd, Shanghai, 200003, China.
Chen W; Department of Hematology, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China.
Fu W; Department of Hematology, The Myeloma & Lymphoma Center, Shanghai Changzheng Hospital, The Second Military Medical University, 415 Fengyang Rd, Shanghai, 200003, China. .
Hou J; Department of Hematology, The Myeloma & Lymphoma Center, Shanghai Changzheng Hospital, The Second Military Medical University, 415 Fengyang Rd, Shanghai, 200003, China. .
Pokaż więcej
Źródło :
Annals of hematology [Ann Hematol] 2020 Aug; Vol. 99 (8), pp. 1779-1791. Date of Electronic Publication: 2020 Jun 27.
Typ publikacji :
Comparative Study; Journal Article
Journal Info :
Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9107334 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0584 (Electronic) Linking ISSN: 09395555 NLM ISO Abbreviation: Ann. Hematol. Subsets: MEDLINE
MeSH Terms :
Multiple Myeloma*/blood
Multiple Myeloma*/diagnosis
Multiple Myeloma*/mortality
Immunoglobulin Light Chains/*blood
Neoplasm Proteins/*blood
Adult ; Aged ; Aged, 80 and over ; Disease-Free Survival ; Female ; Humans ; Male ; Middle Aged ; Neoplasm Staging ; Retrospective Studies ; Survival Rate
Czasopismo naukowe
Tytuł :
Sequential allogeneic hematopoietic stem cell transplantation for active refractory/relapsed myeloid malignancies: results of a reduced-intensity conditioning preceded by clofarabine and cytosine arabinoside, a retrospective study on behalf of the SFGM-TC.
Autorzy :
Le Bourgeois A; Department of Hematology, CHU Hôtel Dieu, Place A. Ricordeau, 44093, Nantes Cedex, France. .
Labopin M; Department of Hematology, Hôpital Saint Antoine, Sorbonne University and INSERM UMRs 938, Paris, France.
Marçais A; Department of Hematology, Hôpital Necker-Enfants Malades, Paris, France.
de Latour RP; Department of Hematology, Hôpital Saint Louis & Université Paris 7, Denis Diderot, Paris, France.
Blaise D; Department of Hematology, Centre de Recherche en Cancérologie de Marseille, Institut Paoli Calmettes, Marseille, France.
Chantepie S; Department of Hematology, CHU de Caen, Caen, France.
N'Guyen S; Department of Hematology, Hôpital Salpétrière, Paris, France.
Maillard N; Department of Hematology, Hôpital La Miletrie, Poitiers, France.
Forcade E; Department of Hematology, CHU de Bordeaux, Bordeaux, France.
Yakoub-Agha I; LIRIC INSERM U995, Université Lille 2, CHU de Lille, Lille, France.
Huynh A; Department of Hematology, CHU de Toulouse, Toulouse, France.
Marchand T; Department of Hematology, CHU de Rennes, Rennes, France.
Bilger K; Department of Hematology, CHU de Strasbourg, Strasbourg, France.
Ceballos P; Department of Hematology, CHU de Montpellier, Montpellier, France.
Charbonnier A; Department of Hematology, CHU d'Amiens Sud, Amiens, France.
Turlure P; Department of Hematology, CHU de Limoges, Limoges, France.
Rubio MT; Department of Hematology, CHU de Nancy, Nancy, France.
Béné MC; Department of Hematology, CHU Hôtel Dieu, Place A. Ricordeau, 44093, Nantes Cedex, France.
Guillaume T; Department of Hematology, CHU Hôtel Dieu, Place A. Ricordeau, 44093, Nantes Cedex, France.
Mohty M; Department of Hematology, Hôpital Saint Antoine, Sorbonne University and INSERM UMRs 938, Paris, France.
Chevallier P; Department of Hematology, CHU Hôtel Dieu, Place A. Ricordeau, 44093, Nantes Cedex, France. .
Pokaż więcej
Corporate Authors :
Société Francophone de Greffe de Moelle et de Thérapie Cellulaire
Źródło :
Annals of hematology [Ann Hematol] 2020 Aug; Vol. 99 (8), pp. 1855-1862. Date of Electronic Publication: 2020 Jun 20.
Typ publikacji :
Clinical Trial; Journal Article; Multicenter Study
Journal Info :
Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9107334 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0584 (Electronic) Linking ISSN: 09395555 NLM ISO Abbreviation: Ann. Hematol. Subsets: MEDLINE
MeSH Terms :
Hematopoietic Stem Cell Transplantation*
Leukemia, Myeloid, Acute*/mortality
Leukemia, Myeloid, Acute*/therapy
Myelodysplastic Syndromes*/mortality
Myelodysplastic Syndromes*/therapy
Transplantation Conditioning*
Antineoplastic Combined Chemotherapy Protocols/*administration & dosage
Adolescent ; Adult ; Aged ; Allografts ; Clofarabine/administration & dosage ; Cytarabine/administration & dosage ; Disease-Free Survival ; Female ; Humans ; Male ; Middle Aged ; Retrospective Studies ; Survival Rate
Czasopismo naukowe
Tytuł :
Risk factors and associations with clinical outcomes of cytomegalovirus reactivation after haploidentical versus matched-sibling unmanipulated PBSCT in patients with hematologic malignancies.
Autorzy :
Gao XN; Department of Hematology, Chinese PLA General Hospital, Beijing, 100853, China.
Lin J; Institute of Basic Medicine, Graduate School, Chinese PLA General Hospital, Beijing, 100853, China.
Wang LJ; Department of Hematology, Chinese PLA General Hospital, Beijing, 100853, China.
Li F; Department of Hematology, Chinese PLA General Hospital, Beijing, 100853, China.
Li HH; Department of Hematology, Chinese PLA General Hospital, Beijing, 100853, China.
Wang SH; Department of Hematology, Chinese PLA General Hospital, Beijing, 100853, China.
Huang WR; Department of Hematology, Chinese PLA General Hospital, Beijing, 100853, China.
Gao CJ; Department of Hematology, Chinese PLA General Hospital, Beijing, 100853, China.
Yu L; Department of Hematology, Chinese PLA General Hospital, Beijing, 100853, China.
Liu DH; Department of Hematology, Chinese PLA General Hospital, Beijing, 100853, China. .
Pokaż więcej
Źródło :
Annals of hematology [Ann Hematol] 2020 Aug; Vol. 99 (8), pp. 1883-1893. Date of Electronic Publication: 2020 Jun 22.
Typ publikacji :
Journal Article
Journal Info :
Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9107334 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0584 (Electronic) Linking ISSN: 09395555 NLM ISO Abbreviation: Ann. Hematol. Subsets: MEDLINE
MeSH Terms :
Hematologic Neoplasms*/mortality
Hematologic Neoplasms*/therapy
Hematologic Neoplasms*/virology
Peripheral Blood Stem Cell Transplantation*
Siblings*
Virus Activation*
Cytomegalovirus/*physiology
Cytomegalovirus Infections/*mortality
Adolescent ; Adult ; Allografts ; Child ; Disease-Free Survival ; Female ; Humans ; Male ; Middle Aged ; Retrospective Studies ; Risk Factors ; Survival Rate
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies